Duncan Gallagher
CIK: 0001780880
Duncan Gallagher's purchase track record
Duncan Gallagher has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/18/2022 | HCAT | $175K | -17.1% | +17.7% | -4.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HCAT | ▲ Buy | Grant | 7,562 | $0 | 2/17/2026 | View on chart |
| HCAT | ▲ Buy | Grant | 6,209 | $0 | 12/1/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 4,970 | $0 | 9/1/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 36,231 | $0 | 7/9/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 4,080 | $0 | 6/1/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 3,033 | $0 | 3/1/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 4,500 | $31K | 12/30/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 4,500 | $31K | 12/23/2024 | View on chart |
| HCAT | ▲ Buy | Grant | 2,001 | $0 | 12/1/2024 | View on chart |
| HCAT | ▲ Buy | Grant | 2,414 | $0 | 9/1/2024 | View on chart |
| HCAT | ▲ Buy | Grant | 20,807 | $0 | 6/13/2024 | View on chart |
| HCAT | ▲ Buy | Grant | 12,505 | $0 | 6/14/2023 | View on chart |
| HCAT | ▲ Buy | Grant | 5,806 | $0 | 6/14/2023 | View on chart |
| HCAT | ▲ Buy | Open Market | 6,600 | $77K | 8/19/2022 | View on chart |
| HCAT | ▲ Buy | Open Market | 8,400 | $98K | 8/18/2022 | View on chart |
| HCAT | ▲ Buy | Grant | 11,677 | $0 | 6/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Health Catalyst Included in List of Unprofitable Stocks
Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.
Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.